We are developing new approaches for MRI of inhaled tracer gases. This involves development of new scanner software, hardware and data analysis methods.
Our studies of inert fluorocarbon gases as MR-visible inhalable tracer gases are focused on providing quantitative imaging-based measurements of lung structure and function that have scope for development through to clinical practice.
Gas MRI presents challenges compared to conventional MRI due to the low concentration of MR-visible tracers in the lung. We are developing of research methods that overcome these challenges with integrated MRI scanner hardware and scan acquisition methodology developments.
View Dr Pete Thelwall’s staff profile.